Qualitative and quantitative metabolomic investigation of single neurons by capillary electrophoresis electrospray ionization mass spectrometry

Single-cell mass spectrometry (MS) empowers metabolomic investigations by decreasing analytical dimensions to the size of individual cells and subcellular structures. We describe a protocol for investigating and quantifying metabolites in individual isolated neurons using single-cell capillary elect...

Full description

Saved in:
Bibliographic Details
Published in:Nature protocols Vol. 8; no. 4; pp. 783 - 799
Main Authors: Nemes, Peter, Rubakhin, Stanislav S, Aerts, Jordan T, Sweedler, Jonathan V
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-04-2013
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Single-cell mass spectrometry (MS) empowers metabolomic investigations by decreasing analytical dimensions to the size of individual cells and subcellular structures. We describe a protocol for investigating and quantifying metabolites in individual isolated neurons using single-cell capillary electrophoresis (CE) coupled to electrospray ionization (ESI) time-of-flight (TOF) MS. The protocol requires ∼2 h for sample preparation, neuron isolation and metabolite extraction, and 1 h for metabolic measurement. We used the approach to detect more than 300 distinct compounds in the mass range of typical metabolites in various individual neurons (25–500 μm in diameter) isolated from the sea slug ( Aplysia californica ) central and rat ( Rattus norvegicus ) peripheral nervous systems. We found that a subset of identified compounds was sufficient to reveal metabolic differences among freshly isolated neurons of different types and changes in the metabolite profiles of cultured neurons. The protocol can be applied to the characterization of the metabolome in a variety of smaller cells and/or subcellular domains.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: US Food and Drug Administration, 10903 New Hampshire Ave., Building 64, Room 3068, Silver Spring, MD 20993, USA. peter.nemes@fda.hhs.gov
ISSN:1754-2189
1750-2799
1750-2799
DOI:10.1038/nprot.2013.035